Health Canada has posted a recall for two lots of Taro-Candesartan 8 mg tablets after the manufacturer said the affected lots may contain esomeprazole 20 mg capsules. The notice, dated Nov. 17, covers a prescription blood pressure medication and applies across the country.
What was recalled
The recall involves Taro-Candesartan tablets in the 8 mg strength, under Drug Identification Number (DIN) 02380692. Two lot numbers are named: PTG5442A and PTG5443A. The company responsible is Sun Pharma Canada Inc., based in Brampton, Ont. Health Canada lists the recall as Type II and gives it the recall number RA-82965.
Health Canada says the problem is that the affected lots may contain esomeprazole 20 mg capsules. In plain terms, a different medication may have ended up in a bottle labelled as candesartan. Esomeprazole is a different drug, generally used to reduce stomach acid, and it comes as a capsule rather than a tablet. The notice does not say how many bottles are affected or how the mix-up happened.
Who may be affected
Health Canada lists the distribution as national, down to the retail level. That means pharmacies in any province or territory could have received the lots. The notice does not name provinces, so readers should not assume their region is spared.
Candesartan is a prescription medicine commonly used to treat high blood pressure and, in some patients, heart failure. Many people take it every day for years, so a recall like this can reach a lot of households quietly. The notice does not describe a specific health hazard, and Health Canada has not said whether anyone has been harmed.
What Health Canada says to do
The recall page asks people to check whether the product they have is affected. A few practical steps follow from that guidance:
- Look at the label on your bottle or pharmacy package. It should show the brand name Taro-Candesartan, the 8 mg strength and a lot number. If the lot number is PTG5442A or PTG5443A, the product is part of this recall.
- If you cannot find a lot number, ask your pharmacist to look it up. Pharmacies keep records of what they dispensed.
- Do not stop taking a prescribed blood pressure medication on your own. Health Canada says to talk to a health care provider before stopping the product or if you have any health concerns.
- Contact the company with questions. Health Canada points readers to Sun Pharma Canada Inc. for more information.
If a tablet looks different from what you usually take, or if a capsule turns up in a bottle of tablets, that is worth showing to a pharmacist right away rather than waiting.
Reporting problems
Health Canada encourages Canadians to report side effects linked to a health product through its adverse reaction reporting system. Other safety complaints, such as packaging or labelling concerns, can be reported through the department’s complaint process. These reports help the department decide whether a recall should be widened.
A note on the dates
The Health Canada page lists the notice as issued on Nov. 17, 2026. Some of the date fields on the page are not consistent with each other, and no separate recall start date is given. We are reporting the Nov. 17 issue date because it is the one the page states as the original publication date.
Why mix-ups matter
A mix-up of this kind carries a particular risk. People trust that what is in the bottle matches what is on the label, and they rarely have a way to check on their own. That is why pharmacists are the first stop. They can compare the lot number with the recall, look at the product and advise on next steps.
Anyone who takes candesartan from a different brand or a different lot is not covered by this notice. Health Canada’s recall database lets people search by product name or DIN, and it is updated as new information arrives.
Sources: Health Canada recall notice RA-82965, Taro-Candesartan; Health Canada Recalls and Safety Alerts
This article is based on official guidance from Health Canada and is provided for general public information. It’s not a substitute for medical advice. If you have questions about how this applies to you, talk to your doctor or pharmacist.
If you find reporting like this useful, consider supporting Canada News Media, an independent Canadian newsroom with no corporate parent.
Follow Canada News Media
Get the day's top Canadian stories and our two daily 60-second news videos wherever you scroll.
X Threads Facebook Instagram LinkedIn TikTok YouTube Pinterest Reddit Substack Flipboard Newsletter RSS













